Related Experiment Video
Updated: May 2, 2026

Real-Time Monitoring and Modulation of Blood Pressure in a Rabbit Model of Ischemic Stroke
Published on: February 10, 2023
Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and
Pablo E Pergola1, Carole L White2, Jeff M Szychowski3
1Department of Medicine, University of Texas Health Sciences Center at San Antonio and Renal Associates PA, San Antonio, Texas;
Insights
Lowering blood pressure (BP) to <130mm Hg after stroke is achievable and safe. Protocol-driven care effectively reduced BP in diverse patient groups, supporting stroke prevention strategies.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Clinical Trials
Background:
- Blood pressure management post-stroke presents significant challenges, even within clinical trials.
- The Secondary Prevention of Small Subcortical Strokes (SPS3) study investigated blood pressure (BP) protocols and achieved BP levels.
Purpose of the Study:
- To describe the BP management protocol used in the SPS3 trial.
- To analyze achieved BP levels in patients with recent symptomatic lacunar stroke.
- To examine BP management across different racial/ethnic groups and baseline conditions.
Main Methods:
- Patients were randomized to a lower systolic BP (SBP) target (<130mm Hg) or a higher target (130-149mm Hg).
- SBP management was monitored throughout the trial.
- Medication use and time to reach target BP were assessed.
Main Results:
- Mean SBP decreased in both groups, reaching 126.7mm Hg (lower target) and 137.4mm Hg (higher target).
- Antihypertensive medication use increased from baseline to study end.
- Black participants showed a higher proportion of SBP ≥150mm Hg compared to White and Hispanic participants.
Conclusions:
- Safely achieving SBP <130mm Hg is feasible in diverse patient populations and settings.
- Protocol-driven care is effective in lowering BP and can help reduce the stroke burden.
- Findings support the implementation of standardized BP management protocols for stroke prevention.
Background:
Lowering blood pressure (BP) after stroke remains a challenge, even in the context of clinical trials. The Secondary Prevention of Small Subcortical Strokes (SPS3) BP protocol, BP management during the study, and achieved BPs are described here.
Methods:
Patients with recent symptomatic lacunar stroke were randomized to 1 of 2 levels of systolic BP (SBP) targets: lower: <130mm Hg, or higher: 130-149mm Hg. SBP management over the course of the trial was examined by race/ethnicity and other baseline conditions.
Results:
Mean SBP decreased for both groups from baseline to the last follow-up, from 142.4 to 126.7mm Hg for the lower SBP target group and from 143.6 to 137.4mm Hg for the higher SBP target group. At baseline, participants in both groups used an average of 1.7±1.2 antihypertensive medications, which increased to a mean of 2.4±1.4 (lower group) and 1.8±1.4 (higher group) by the end-study visit. It took an average of 6 months for patients to reach their SBP target, sustained to the last follow-up. Black participants had the highest proportion of SBP ≥150mm Hg at both study entry (40%) and end-study visit (17%), as compared with whites (9%) and Hispanics (11%).
Conclusions:
These results show that it is possible to safely lower BP even to a SBP goal <130mm Hg in a variety of patients and settings, including private and academic centers in multiple countries. This provides further support for protocol-driven care in lowering BP and consequently reducing the burden of stroke.
Related Concept Videos
Errors occurring during blood pressure monitoring
Several factors...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pre-Procedural Guidelines for Assessing Blood Pressure
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Factors affecting Blood pressure
Physiological Factors:
Atherosclerosis III: Management
